RGD peptide-based non-viral gene delivery vectors targeting integrin α v β 3 for cancer therapy

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Cancer statistics, 2016

Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003 · see citing works

Angiogenesis in cancer, vascular, rheumatoid and other disease

Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627 · see citing works

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

Pierschbacher, M. D., & Ruoslahti, E. I. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,670 · see citing works

Requirement of Vascular Integrin α _v β ₃ for Angiogenesis

Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020 · see citing works

Design and development of polymers for gene delivery

Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568 · see citing works

Active targeting schemes for nanoparticle systems in cancer therapeutics

Byrne, J. D., Betancourt, T., & Brannon‐Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,732 · see citing works

Structural Basis of Integrin Regulation and Signaling

Luo, B., Carman, C. V., & Springer, T. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141618 · Cited by 1,662 · see citing works

Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes

Rädler, J. O., Koltover, I., Salditt, T., & Safinya, C. R. (1997) · Science · doi:10.1126/science.275.5301.810 · Cited by 1,411 · see citing works

Ligand Binding to Integrins

Plow, E. F., Haas, T. A., Zhang, L., Loftus, J. C., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,359 · see citing works

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140 · see citing works

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. I. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,080 · see citing works

RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis

Danhier, F., Breton, A. L., & Véronique Préat, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 959 · see citing works

Cell Spreading and Focal Adhesion Dynamics Are Regulated by Spacing of Integrin Ligands

Cavalcanti‐Adam, E. A., Volberg, T., Micoulet, A., Kessler, H., Geiger, B., & Spatz, J. P. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.089730 · Cited by 924 · see citing works

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 900 · see citing works

Chitosan-based gastrointestinal delivery systems

Hejazi, R., & Amiji, M. M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 884 · see citing works

<i>N</i> -Methylated Cyclic RGD Peptides as Highly Active and Selective α _V β ₃ Integrin Antagonists

Dechantsreiter, M. A., Planker, E., Mathä, B., Lohof, E., Hölzemann, G., Jonczyk, A., Goodman, S. L., & Kessler, H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm970832g · Cited by 838 · see citing works

Targeting of drugs and nanoparticles to tumors

Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 833 · see citing works

Prospects for cationic polymers in gene and oligonucleotide therapy against cancer

Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785 · see citing works

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer

Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoît, J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769 · see citing works

Advantages of RGD peptides for directing cell association with biomaterials

Bellis, S. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.029 · Cited by 746 · see citing works

Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro

Grant, D. S., Tashiro, K., Seguí‐Real, B., Yamada, Y., Martin, G. R., & Kleinman, H. K. (1989) · Cell · doi:10.1016/0092-8674(89)90945-8 · Cited by 740 · see citing works

Ion-pairs in proteins

Barlow, D. J., & Thornton, J. M. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80079-5 · Cited by 712 · see citing works

An overview of current delivery systems in cancer gene therapy

El‐Aneed, A. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 694 · see citing works

Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion.

Pierschbacher, M. D., & Ruoslahti, E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45376-8 · Cited by 651 · see citing works

Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1

Aumailley, M., Gurrath, M., Müller, G., Calvete, J. J., Timpl, R., & Kessler, H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81101-d · Cited by 552 · see citing works

Impact of Order and Disorder in RGD Nanopatterns on Cell Adhesion

Huang, J., Gräter, S., Corbellini, F., Rinck, S., Bock, E., Kemkemer, R., Kessler, H., Ding, J., & Spatz, J. P. (2009) · Nano Letters · doi:10.1021/nl803548b · Cited by 544 · see citing works

Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.

Lawler, J., Weinstein, R. S., & Hynes, R. O. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.6.2351 · Cited by 481 · see citing works

Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins

Koivunen, E., Wang, B., & Ruoslahti, E. (1995) · Nature Biotechnology · doi:10.1038/nbt0395-265 · Cited by 477 · see citing works

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

Temming, K., Schiffelers, R. M., Molema, G., & Kok, R. J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.10.002 · Cited by 467 · see citing works

Hydrogen bonds and salt bridges across protein-protein interfaces

Xu, D., Tsai, C.-J., & Nussinov, R. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.9.999 · Cited by 457 · see citing works

Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts.

Miyauchi, A., Alvarez, J., Greenfield, E. M., Teti, A. M., Grano, M., Colucci, S. C., Zambonin-Zallone, A., Ross, F. P., Teitelbaum, S. L., & Cheresh, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54932-2 · Cited by 394 · see citing works

Gene therapy clinical trials worldwide 1989–2004—an overview

Edelstein, M. L., Abedi, M. R., Wixon, J., & Edelstein, R. M. (2004) · Journal of Gene Medicine · doi:10.1002/jgm.619 · Cited by 371 · see citing works

The mechanisms and dynamics of αvβ3 integrin clustering in living cells

Cluzel, C., Saltel, F., Lussi, J. W., Paulhe, F., Imhof, B. A., & Wehrle‐Haller, B. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503017 · Cited by 351 · see citing works

Radiolabeled Cyclic RGD Peptides as Integrin αvβ3-Targeted Radiotracers: Maximizing Binding Affinity via Bivalency

Liu, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900167c · Cited by 342 · see citing works

Radiolabeled Multimeric Cyclic RGD Peptides as Integrin α v β 3 Targeted Radiotracers for Tumor Imaging

Liu, S. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060049x · Cited by 339 · see citing works

Linking integrin conformation to function

Askari, J. A., Buckley, P. A., Mould, A. P., & Humphries, M. J. (2008) · Journal of Cell Science · doi:10.1242/jcs.018556 · Cited by 323 · see citing works

Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial

Cook, A. D., Hrkach, J. S., Gao, N. N., Johnson, I. M., Pajvani, U. B., Cannizzaro, S. M., & Langer, R. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19970615)35:4 · Cited by 318 · see citing works

An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization

Drake, C. J., Cheresh, D. A., & Little, C. D. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.7.2655 · Cited by 307 · see citing works

Induction of Cell Polarization and Migration by a Gradient of Nanoscale Variations in Adhesive Ligand Spacing

Arnold, M., Hirschfeld‐Warneken, V. C., Lohmüller, T., Heil, P., Blümmel, J., Cavalcanti‐Adam, E. A., López‐García, M., Walther, P., Kessler, H., Geiger, B., et al. (2008) · Nano Letters · doi:10.1021/nl801483w · Cited by 305 · see citing works

Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting

Meyer, A., Auernheimer, J., Modlinger, A., & Kessler, H. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947740 · Cited by 293 · see citing works

Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles

Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D.-Y., Nam, E. J., Mora, E., Stone, R. L., Lü, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 281 · see citing works

Multimeric Cyclic RGD Peptides as Potential Tools for Tumor Targeting: Solid‐Phase Peptide Synthesis and Chemoselective Oxime Ligation

Thumshirn, G., Hersel, U., Goodman, S. L., & Kessler, H. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204304 · Cited by 269 · see citing works

Integrin Targeted Delivery of Chemotherapeutics

Chen, K., & Chen, X. S. (2011) · Theranostics · doi:10.7150/thno/v01p0189 · Cited by 241 · see citing works

Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway

Erbacher, P., Remy, J.-S., & Behr, J. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300783 · Cited by 236 · see citing works

Interactions of Phospholipid Bilayer with Chitosan: Effect of Molecular Weight and pH

Fang, N., Chan, V., Mao, H., & Leong, K. W. (2001) · Biomacromolecules · doi:10.1021/bm015548s · Cited by 231 · see citing works

Radiolabelled RGD peptides for imaging and therapy

Gaertner, F. C., Kessler, H., Wester, H. J., Schwaiger, M., & Beer, A. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2028-1 · Cited by 226 · see citing works

An Acid-Labile Block Copolymer of PDMAEMA and PEG as Potential Carrier for Intelligent Gene Delivery Systems

Lin, S. B., Du, F., Wang, Y., Ji, S., Liang, D., Yu, L. M., & Li, Z. (2007) · Biomacromolecules · doi:10.1021/bm7008747 · Cited by 225 · see citing works

Forty-Year Journey of Angiogenesis Translational Research

Cao, Y., Arbiser, J. L., D’Amato, R. J., D'Amore, P. A., Ingber, D. E., Kerbel, R. S., Klagsbrun, M., Lim, S., Moses, M. A., Zetter, B. R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003149 · Cited by 223 · see citing works

Imaging of integrin αvβ3 expression

Beer, A. J., & Schwaiger, M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9158-3 · Cited by 211 · see citing works

Cationic liposomal lipids: From gene carriers to cell signaling

Lonez, C., Vandenbranden, M., & Ruysschaert, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.03.002 · Cited by 208 · see citing works

Solution stability of linear vs. cyclic RGD peptides

Bogdanowich-Knipp, S. J., Chakrabarti, S., Siahaan, T. J., Williams, T. D., & Dillman, R. K. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00052.x · Cited by 206 · see citing works

Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery

Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.012 · Cited by 199 · see citing works

The RGD story: a personal account

Ruoslahti, E. I. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00083-0 · Cited by 189 · see citing works

Synthesis, surface, and cell‐adhesion properties of polyurethanes containing covalently grafted RGD‐peptides

Lin, H., Sun, W., Mosher, D. F., Garcı́a-Echeverrı́a, C., Schaufelberger, K., Lelkes, P. I., & Cooper, S. L. (1994) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820280307 · Cited by 178 · see citing works

Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor

Beer, J. H., Springer, K., & Coller, B. (1992) · Blood · doi:10.1182/blood.v79.1.117.117 · Cited by 161 · see citing works

Amino acid sequence of the murine Mac‐1 alpha chain reveals homology with the integrin family and an additional domain related to von Willebrand factor.

Pytela, R. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02953.x · Cited by 160 · see citing works

Solution Structures and Integrin Binding Activities of an RGD Peptide with Two Isomers

Assa‐Munt, N., Jia, X., Laakkonen, P. M., & Ruoslahti, E. I. (2001) · Biochemistry · doi:10.1021/bi002101f · Cited by 157 · see citing works

Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin

Jiang, J., Yang, S.-J., Wang, J., Yang, L., Xu, Z.-Z., Yang, T., Liu, X.-Y., & Zhang, Q. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.011 · Cited by 149 · see citing works

Endothelial cell adhesion on polyurethanes containing covalently attached RGD-peptides

Lin, H., Garcı́a-Echeverrı́a, C., Asakura, S., Sun, W., Mosher, D. F., & Cooper, S. L. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90113-3 · Cited by 145 · see citing works

Nanoparticles for Gene Delivery

Tian, H., Chen, J., & Chen, X. (2013) · Small · doi:10.1002/smll.201202485 · Cited by 140 · see citing works

Tumor-Penetrating iRGD Peptide Inhibits Metastasis

Sugahara, K. N., Braun, G. B., de Mendoza, T. H., Kotamraju, V. R., French, R. P., Lowy, A. M., Teesalu, T., & Ruoslahti, E. I. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0366 · Cited by 135 · see citing works

Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3

Yu, Y.-P., Wang, Q., Liu, Y., & Xie, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.072 · Cited by 131 · see citing works

Highly branched HK peptides are effective carriers of siRNA

Leng, Q., Scaria, P. V., Zhu, J., Ambulos, N. P., Campbell, P., & Mixson, A. J. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.748 · Cited by 129 · see citing works

αvβ3‐ or α5β1‐Integrin‐Selective Peptidomimetics for Surface Coating

Mas‐Moruno, C., Fraioli, R., Rechenmacher, F., Neubauer, S., Kapp, T. G., & Kessler, H. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509782 · Cited by 123 · see citing works

Conformational Changes in the Integrin औA Domain Provide a Mechanism for Signal Transduction via Hybrid Domain Movement

Mould, A. P., Barton, S., Askari, J. A., McEwan, P., Buckley, P. A., Craig, S. E., & Humphries, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213139200 · Cited by 122 · see citing works

Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering

Guo, Z., He, B., Jin, H., Zhang, H., Dai, W., Zhang, L., Zhang, H., Wang, X., Wang, J., Zhang, X., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.031 · Cited by 112 · see citing works

Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects

Song, Z., Lin, Y., Zhang, X., Feng, C., Lu, Y., Gao, Y., & Dong, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125573 · Cited by 110 · see citing works

Synthetic peptide-based DNA complexes for nonviral gene delivery

Smith, L. C., Duguid, J. G., Wadhwa, M. S., Logan, M., Tung, C., Edwards, V., & Sparrow, J. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00111-7 · Cited by 103 · see citing works

A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy

Park, J. Y., Singha, K., Son, S., Kim, J., Namgung, R., Yun, C.-O., & Kim, W.-J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.64 · Cited by 99 · see citing works

HPMA copolymer–cyclic RGD conjugates for tumor targeting☆☆☆

Pike, D. B., & Ghandehari, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.027 · Cited by 99 · see citing works

Structural Insights into How the MIDAS Ion Stabilizes Integrin Binding to an RGD Peptide under Force

Craig, D. W., Gao, M., Schulten, K. J., & Viola Vogel, B. (2004) · Structure · doi:10.1016/j.str.2004.09.009 · Cited by 96 · see citing works

Pharmaceutical Perspectives of Nucleic Acid-Based Therapy

(2002) · CRC Press eBooks · doi:10.1201/b12598 · Cited by 95 · see citing works

The effect of conformation on the solution stability of linear vs. cyclic RGD peptides

Bogdanowich-Knipp, S. J., JOIS, D. S. S., & Siahaan, T. J. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00055.x · Cited by 94 · see citing works

Design and Chemical Synthesis of Integrin Ligands

Heckmann, D., & Kessler, H. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)26020-3 · Cited by 88 · see citing works

Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery

Kim, H., Nam, K., & Kim, S. W. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.021 · Cited by 87 · see citing works

Tailored polymer–lipid hybrid nanoparticles for the delivery of drug conjugate: Dual strategy for brain targeting

Agrawal, U., Chashoo, G., Sharma, P. R., Kumar, A., Saxena, A. K., & Vyas, S. P. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.12.045 · Cited by 84 · see citing works

RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells

Shan, D., Li, J., Cai, P., Prasad, P., Liu, F., Rauth, A. M., & Wu, X. Y. (2014) · Drug Delivery and Translational Research · doi:10.1007/s13346-014-0210-2 · Cited by 83 · see citing works

RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma

Fei, W., Zhang, Y., Han, S., Tao, J., Zheng, H., Wei, Y., Zhu, J., Li, F., & Wang, X. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.031 · Cited by 83 · see citing works

Uptake and transfection efficiency of PEGylated cationic liposome–DNA complexes with and without RGD-tagging

Majzoub, R. N., Chan, C.-L., Ewert, K., Silva, B. F. B., Liang, K., Jacovetty, E. L., Carragher, B., Potter, C., & Safinya, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.007 · Cited by 82 · see citing works

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

Dijkgraaf, I. (2009) · Frontiers in bioscience · doi:10.2741/3284 · Cited by 81 · see citing works

Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection

Leng, Q. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni040 · Cited by 80 · see citing works

Function and Antagonism of β Integrins in the Development of Cancer Therapy

Sheldrake, H. M., & Patterson, L. H. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788486713 · Cited by 73 · see citing works

iRGD Conjugated TPGS Mediates Codelivery of Paclitaxel and Survivin shRNA for the Reversal of Lung Cancer Resistance

Shen, J., Meng, Q., Sui, H., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400576f · Cited by 69 · see citing works

Differential structural requirements for fibrinogen binding to platelets and to endothelial cells.

Tranqui, L., Andrieux, A., Hudry-Clergeon, G., Ryckewaert, J. J., Soyez, S., Chapel, A., Ginsberg, M. H., Plow, E. F., & Marguerie, G. A. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.6.2519 · Cited by 68 · see citing works

Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme

Shi, K., Zhou, J., Zhang, Q., Gao, H., Liu, Y., Zong, T., & He, Q. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.1965 · Cited by 64 · see citing works

Chemically modified polysaccharide schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake efficiency

Matsumoto, T. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2003.10.019 · Cited by 61 · see citing works

A Computational Model of Transmembrane Integrin Clustering

Gottschalk, K., & Kessler, H. (2004) · Structure · doi:10.1016/j.str.2004.02.039 · Cited by 58 · see citing works

The Cyclic Cystine Ladder of Theta‐Defensins as a Stable, Bifunctional Scaffold: A Proof‐of‐Concept Study Using the Integrin‐Binding RGD Motif.

Conibear, A. C., Bochen, A., Rosengren, K. J., Stupar, P., Wang, C. K. L., Kessler, H., & Craik, D. J. (2014) · ChemBioChem · doi:10.1002/cbic.201300568 · Cited by 56 · see citing works

Immersion delivery of plasmid DNA II. A study of the potentials of a chitosan based delivery system in rainbow trout (Oncorhynchus mykiss) fry

Romøren, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00278-x · Cited by 55 · see citing works

Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery

Zhao, Y., Lin, D., Wu, F., Guo, L., He, G., Ouyang, L., Song, X., Huang, W., & Li, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017565 · Cited by 54 · see citing works

Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in αvβ3 integrin-overexpressing tumor cells

Kim, Y., Park, S., & Jang, M.-K. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.07.035 · Cited by 53 · see citing works

Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif

Aoki, Y., Hosaka, S., Kawa, S., & Kiyosawa, K. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700362 · Cited by 44 · see citing works

Highly efficient transduction of endothelial cells by targeted artificial virus-like particles

Müller, K., Nahde, T., Fahr, A., Müller, R., & Brüsselbach, S. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700280 · Cited by 44 · see citing works

Gene therapy for rats and mice

Olefsky, J. M. (2000) · Nature · doi:10.1038/35044177 · Cited by 42 · see citing works

Synthesis of linear and cyclic peptide–PEG–lipids for stabilization and targeting of cationic liposome–DNA complexes

Ewert, K. K., Kotamraju, V. R., Majzoub, R. N., Steffes, V. M., Wonder, E. A., Teesalu, T., Ruoslahti, E. I., & Safinya, C. R. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.079 · Cited by 39 · see citing works

Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability

Guo, Z., Zhou, X., Xu, M., Tian, H., Chen, X., & Chen, M. (2017) · Biomaterials Science · doi:10.1039/c7bm00791d · Cited by 37 · see citing works

Synthesis and Characterization of Four-Arm Poly(ethylene glycol)-Based Gene Delivery Vehicles Coupled to Integrin and DNA-Binding Peptides

Moore, N. M., Barbour, T. R., & Sakiyama‐Elbert, S. E. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700072n · Cited by 32 · see citing works

Peptide-mediated Gene Transfer of Cationic Lipid/Plasmid DNA Complexes to Endothelial Cells

Anwer, K., Kao, G., Rolland, A. P., Driessen, W. H. P., & Sullivan, S. M. (2004) · Journal of drug targeting · doi:10.1080/10611860410001724468 · Cited by 30 · see citing works

Molecular Organization of Protein–DNA Complexes for Cell-Targeted DNA Delivery

Arı́s, A., & Villaverde, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3824 · Cited by 27 · see citing works

Exploration of peptide motifs for potent non‐viral gene delivery highly selective for dividing cells

Parker, A. L., Collins, L., Zhang, X., & Fabre, J. W. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.809 · Cited by 20 · see citing works

A Biodegradable Polyethylenimine-Based Vector Modified by Trifunctional Peptide R18 for Enhancing Gene Transfection Efficiency In Vivo

Hu, J., Zhu, M., Liu, K., Fan, H., Zhao, W., Mao, Y., & Zhang, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166673 · Cited by 20 · see citing works

Development of novel poly(ethylene glycol)‐based vehicles for gene delivery

Schmieder, A. H., Grabski, L. E., Moore, N. M., Dempsey, L. A., & Sakiyama‐Elbert, S. E. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21199 · Cited by 19 · see citing works

RGD-derivatized PEI-PEG copolymers: Influence of the degree of substitution on the targeting behavior

Pezzoli, D., Tarsini, P., Melone, L., & Candiani, G. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.12.005 · Cited by 17 · see citing works

Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics

Kumar, M. N. V. R. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00071-3 · Cited by 14 · see citing works

Analysis of Cell Binding and Internalization of Multivalent PEG-Based Gene Delivery Vehicles

Moore, N. M., & Sakiyama‐Elbert, S. E. (2011) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2011.2179555 · Cited by 5 · see citing works

Biodegradable dendritic copolymers consisting of poly(L-lactide) and cRGDfK peptide: synthesis, characterization, and regulation of MC3T3-E1 cell functions

Zhao, C., Yu, J., Peng, R., Rao, M., & Hu, M. (2015) · Designed Monomers & Polymers · doi:10.1080/15685551.2015.1041088 · Cited by 1 · see citing works

Supramolecular engineering with macromolecules: An alternative concept for block copolymers

Lohmeijer, B. G. G., & Schubert, U. S. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20021018)41:20

The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives

Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 442 · see citing works

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

Park, J., Choi, Y., Chang, H., Um, W., Ryu, J. H., & Kwon, I. C. (2019) · Theranostics · doi:10.7150/thno.37198 · Cited by 385 · see citing works

Lysyl oxidases: from enzyme activity to extracellular matrix cross-links

Vallet, S. D., & Ricard‐Blum, S. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180050 · Cited by 338 · see citing works

BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease

Moussa‐Pacha, N. M., Abdin, S. M., Omar, H. A., Alniss, H. Y., & Al‐Tel, T. H. (2019) · Medicinal Research Reviews · doi:10.1002/med.21622 · Cited by 308 · see citing works

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment

Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 295 · see citing works

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions

Javid, H., Oryani, M. A., Rezagholinejad, N., Esparham, A., Tajaldini, M., & Karimi‐Shahri, M. (2024) · Cancer Medicine · doi:10.1002/cam4.6800 · Cited by 286 · see citing works

Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy

Liu, C., Zhang, L., Zhu, W., Guo, R., Sun, H., Chen, X., & Deng, N. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.015 · Cited by 239 · see citing works

Enhancement of EPR Effect for Passive Tumor Targeting: Current Status and Future Perspectives

Vagena, I.-A., Malapani, C., Gatou, Μ.-A., Lаgopati, N., & Pavlatou, E. A. (2025) · Applied Sciences · doi:10.3390/app15063189 · Cited by 232 · see citing works

Are Integrins Still Practicable Targets for Anti-Cancer Therapy?

Alday-Parejo, B., Stupp, R., & Rüegg, C. (2019) · Cancers · doi:10.3390/cancers11070978 · Cited by 175 · see citing works

Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy

Fang, X., Cao, J., & Shen, A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101662 · Cited by 132 · see citing works

Nanovaccine: an emerging strategy

Das, A., & Ali, N. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1984890 · Cited by 131 · see citing works

Recent advances in electrospun nanofiber‐ mediated drug delivery strategies for localized cancer chemotherapy

Khodadadi, M., Alijani, S., Montazeri, M., Esmaeilizadeh, N., Sadeghi‐Soureh, S., & Pilehvar‐Soltanahmadi, Y. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36912 · Cited by 120 · see citing works

Peptide-based gene delivery vectors

Kang, Z., Meng, Q., & Liu, K. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb03124j · Cited by 117 · see citing works

The Microfluidic Technique and the Manufacturing of Polysaccharide Nanoparticles

Chiesa, E., Dorati, R., Pisani, S., Conti, B., Bergamini, G., Modena, T., & Genta, I. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040267 · Cited by 112 · see citing works

Fabrication of tri-layered electrospun polycaprolactone mats with improved sustained drug release profile

Kamath, S. M., Sridhar, K. R., Jaison, D., Gopinath, V., Ibrahim, B. K. M., Gupta, N., Sundaram, A., Sivaperumal, P., Padmapriya, S., & Patil, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-74885-1 · Cited by 107 · see citing works

Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines

Fattahi, N., Shahbazi, M., Maleki, A., Hamidi, M., Ramazani, A., & Santos, H. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.012 · Cited by 101 · see citing works

Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis

Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98 · see citing works

A review of the tortuous path of nonviral gene delivery and recent progress

Sharma, D., Arora, S., Singh, J., & Layek, B. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.05.192 · Cited by 93 · see citing works

Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications

Lin, Z., Goswami, N., Xue, T., Chai, O. J. H., Xu, H., Liu, Y., Su, Y., & Xie, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202105662 · Cited by 89 · see citing works

Current state of the art in peptide-based gene delivery

Hadianamrei, R., & Zhao, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.010 · Cited by 78 · see citing works

Targeted Drug Delivery via the Use of ECM-Mimetic Materials

Hwang, J., Sullivan, M. O., & Kiick, K. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00069 · Cited by 74 · see citing works

Microfluidics Technology for the Design and Formulation of Nanomedicines

Jaradat, E., Weaver, E., Meziane, A., & Lamprou, D. A. (2021) · Nanomaterials · doi:10.3390/nano11123440 · Cited by 70 · see citing works

Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment

Aghamiri, S., Talaei, S., Ghavidel, A. A., Zandsalimi, F., Masoumi, S., Hafshejani, N. H., & Jajarmi, V. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101533 · Cited by 69 · see citing works

Cell-penetrating peptides for transmucosal delivery of proteins

Wu, J., Roesger, S., Jones, N. B., Hu, C. J., & Li, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.038 · Cited by 68 · see citing works

Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management

Allemailem, K. S., Alsahli, M. A., Almatroudi, A., Alrumaihi, F., Alkhaleefah, F. K., Rahmani, A. H., & Khan, A. A. (2022) · 癌症：英文版 · doi:10.1002/cac2.12366 · Cited by 69 · see citing works

Nanotechnology applications for cardiovascular disease treatment: Current and future perspectives

Wang, D. K., Rahimi, M., & Filgueira, C. S. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102387 · Cited by 66 · see citing works

Integrin αvβ3-targeted liposomal drug delivery system for enhanced lung cancer therapy

Fu, S., Zhao, Y., Sun, J., Yang, T., Zhi, D., Zhang, E. X., Zhong, F., Zhen, Y., Zhang, S., & Zhang, S. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111623 · Cited by 64 · see citing works

Recent research progress of biologically active peptides

Kang, L., Han, T., Cong, H., Yu, B., & Shen, Y. (2022) · BioFactors · doi:10.1002/biof.1822 · Cited by 58 · see citing works

Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer

Sani, S., Messé, M., Fuchs, Q., Pierrevelcin, M., Laquerrière, P., Entz‐Werlé, N., Reita, D., Étienne-Selloum, N., Bruban, V., Choulier, L., et al. (2020) · ChemBioChem · doi:10.1002/cbic.202000626 · Cited by 56 · see citing works

Recent advances in dual-ligand targeted nanocarriers for cancer therapy

Khan, N., Ruchika, Dhritlahre, R. K., & Saneja, A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.04.011 · Cited by 55 · see citing works

Comparison of Linear vs. Cyclic RGD Pentapeptide Interactions with Integrin αvβ3 by Molecular Dynamics Simulations

Li, N., Qiu, S., Fang, Y. G., Wu, J., & Li, Q. (2021) · Biology · doi:10.3390/biology10070688 · Cited by 54 · see citing works

Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: Conjugation chemistry and alternative therapeutic strategies

Dhas, N. L., Kudarha, R. R., Pandey, A. P., Nikam, A. N., Sharma, S., Singh, A. K., Garkal, A., Hariharan, K., Singh, A., Bangar, P., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.021 · Cited by 50 · see citing works

Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy

Yin, L., Li, X., Wang, R., Zeng, Y., Zeng, Z., & Xie, T. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10523-4 · Cited by 48 · see citing works

Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles

Huang, J., Lai, W., Wang, Q., Tang, Q., Hu, C., Zhou, M., Wang, F., Xie, D., Zhang, Q., Liu, W., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s321071 · Cited by 47 · see citing works

WS 2 nanosheets functionalized by biomimetic lipids with enhanced dispersibility for photothermal and chemo combination therapy

Xie, M., Yang, M., Sun, X., Yang, N., Deng, T., Li, Y., & Shen, H. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb01604j · Cited by 47 · see citing works

Protein corona: challenges and opportunities for targeted delivery of nanomedicines

Jiang, Z., Chu, Y., & Zhan, C. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2093854 · Cited by 46 · see citing works

Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization

Rodà, F., Caraffi, R., Picciolini, S., Tosi, G., Vandelli, M. A., Ruozi, B., Bedoni, M., Ottonelli, I., & Duskey, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032496 · Cited by 42 · see citing works

Pure DNA scaffolded drug delivery systems for cancer therapy

Aliouat, H., Peng, Y., Waseem, Z., Wang, S., & Zhou, W. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121532 · Cited by 37 · see citing works

Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery

Liu, Y., Xie, X., Chen, H., Hou, X., He, Y., Shen, J., Shi, J.-P., & Feng, N. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102237 · Cited by 36 · see citing works

Nanofibrillar peptide hydrogels for self-delivery of lonidamine and synergistic photodynamic therapy

Wu, C., Jiao, Q., Wang, C., Zheng, Y., Pan, X., Zhong, W., & Xu, K. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.008 · Cited by 35 · see citing works

Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review

Oryani, M. A., Nosrati, S., Javid, H., Mehri, A., Hashemzadeh, A., & Karimi‐Shahri, M. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02707-y · Cited by 34 · see citing works

In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting

Yazdi, M., Pöhmerer, J., Kafshgari, M. H., Seidl, J., Grau, M., Höhn, M., Vetter, V., Hoch, C. C., Wollenberg, B., Multhoff, G., et al. (2024) · Small · doi:10.1002/smll.202400643 · Cited by 34 · see citing works

The inhibition of miR-17-5p promotes cortical neuron neurite growth via STAT3/GAP-43 pathway

Zhang, L., Wang, Z., Li, B., Xia, Z., Wang, X., Xiu, Y., Zhang, Z., Chen, C., Song, H., Li, W., et al. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05273-1 · Cited by 34 · see citing works

Two-photon photodynamic ablation of tumour cells using an RGD peptide-conjugated ruthenium( ii ) photosensitiser

Zhao, Z., Qiu, K., Liu, J., Hao, X., & Wang, J. (2020) · Chemical Communications · doi:10.1039/d0cc04943c · Cited by 34 · see citing works

Dual‐Targeting Peptides RGD10‐NGR9‐Conjugated Lanthanide Nanoparticle@Polydopamine as Upconversion Nanoprobes for In Vivo Imaging of Lung Cancer

Cao, J., Zhang, L., Ding, X., Liu, D., Su, B., & Shi, J. (2020) · Small Methods · doi:10.1002/smtd.202000648 · Cited by 34 · see citing works

Passive and active targeting strategies in hybrid layered double hydroxides nanoparticles for tumor bioimaging and therapy

Nava-Andrade, K., Puebla‐Pérez, A. M., & Arízaga, G. G. C. (2019) · Applied Clay Science · doi:10.1016/j.clay.2019.105214 · Cited by 33 · see citing works

Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System

Liufu, C., Li, Y., Tu, J., Zhang, H., Yu, J., Wang, Y., Huang, P., & Chen, Z. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s217338 · Cited by 33 · see citing works

A novel progress of drug delivery system for organelle targeting in tumour cells

He, Z., Zhang, Y., Khan, A. R., Ji, J., Yu, A., & Zhai, G. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1797051 · Cited by 32 · see citing works

Peptide therapeutics in the management of metastatic cancers

Bose, D., Roy, L., & Chatterjee, S. (2022) · RSC Advances · doi:10.1039/d2ra02062a · Cited by 26 · see citing works

Integrin-Mediated Delivery of Drugs and Nucleic Acids for Anti-Angiogenic Cancer Therapy: Current Landscape and Remaining Challenges

Majumder, P. (2018) · Bioengineering · doi:10.3390/bioengineering5040076 · Cited by 25 · see citing works

Unlocking the potential of RGD-conjugated gold nanoparticles: a new frontier in targeted cancer therapy, imaging, and metastasis inhibition

Javid, H., Oryani, M. A., Rezagholinejad, N., Hashemzadeh, A., & Karimi‐Shahri, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00281d · Cited by 24 · see citing works

Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights

Zhang, Z., Tang, Y., Luo, D., Qiu, J. L., & Chen, L. (2025) · APL Bioengineering · doi:10.1063/5.0244706 · Cited by 23 · see citing works

Coaxial electrostatic spray-based preparation of localization missile liposomes on a microfluidic chip for targeted treatment of triple-negative breast cancer

Wang, Q., Xu, W., Li, Q., He, C., Liu, Y., Liu, J., Wang, R., Wu, J., Xiang, D., & Chen, C. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123220 · Cited by 21 · see citing works

Nanomedicine Innovations for Lung Cancer Diagnosis and Therapy

Cardoso, V. M. D. O., Bistaffa, M. J., Sterman, R. G., de Lima, L. L. P., Toldo, G. S., Cancino‐Bernardi, J., & Zucolotto, V. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c16840 · Cited by 21 · see citing works

Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding

Song, Y., Guo, X., Fu, J., He, B., Wang, X., Dai, W., Zhang, H., & Zhang, Q. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.012 · Cited by 20 · see citing works

Redox‐responsive polyethyleneimine‐coated magnetic iron oxide nanoparticles for controllable gene delivery and magnetic resonance imaging

Peng, S. X., Wang, Q., Xiao, X., Wang, R., Lin, J., Zhou, Q., & Wu, L. (2019) · Polymer International · doi:10.1002/pi.5943 · Cited by 20 · see citing works

Energy Conversion-Based Nanotherapy for Rheumatoid Arthritis Treatment

Wang, P., Li, A., Yu, L., Chen, Y., & Xu, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00652 · Cited by 19 · see citing works

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells

Egorova, A., Selutin, A. V., Maretina, M. A., Selkov, S. А., Баранов, В. С., & Kiselev, A. (2020) · Pharmaceuticals · doi:10.3390/ph13100300 · Cited by 19 · see citing works

LncRNA nuclear-enriched abundant transcript 1 regulates hypoxia-evoked apoptosis and autophagy via mediation of microRNA-181b

Lv, Y., Liu, Z., Huang, J., Yu, J., Dong, Y., & Wang, J. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03660-2 · Cited by 19 · see citing works

Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma

Zhao, L., Chen, H., Lu, L., Zhao, C., Malichewe, C. V., Wang, L., Guo, X., & Zhang, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119113 · Cited by 19 · see citing works

Solvent Effect on the Structure and Properties of RGD Peptide (1FUV) at Body Temperature (310 K) Using Ab Initio Molecular Dynamics

Baral, K., Adhikari, P., Jawad, B., Podgornik, R., & Ching, W. Y. (2021) · Polymers · doi:10.3390/polym13193434 · Cited by 18 · see citing works

Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression

Wang, H., Liu, N., Yang, F., Hu, N., Wang, M., Cui, M., Bruns, N., & Guan, X. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01221 · Cited by 18 · see citing works

Peptide-Based Vectors for Gene Delivery

Yang, J., & Luo, G. (2023) · Chemistry · doi:10.3390/chemistry5030116 · Cited by 16 · see citing works

iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer

Hou, X., Chen, Q., Fang, Y. G., Zhang, L., Huang, S., Xu, M., Ren, Y., Shi, Z., Wei, Y., & Li, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s474135 · Cited by 16 · see citing works

Current Designs of Polymeric Platforms Towards the Delivery of Nucleic Acids Inside the Cells with Focus on Polyethylenimine

de Oliveira, F. A., Albuquerque, L. J. C., Delecourt, G., Bennevault, V., Guégan, P., & Giacomelli, F. C. (2021) · Current Gene Therapy · doi:10.2174/1566523221666210705130238 · Cited by 15 · see citing works

Interrogating preclinical study of liposomes: The effect of mouse strain reexamined

Guan, J., Wu, E., Jin, P., Hou, S., Qian, J., Lu, W., Yu, B., & Zhan, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.025 · Cited by 15 · see citing works

Arg−Gly−Asp peptide functionalized poly-amino acid/ poly (p-benzamide) copolymer with enhanced mechanical properties and osteogenicity

Chen, L., Wang, B., Ren, H., Wu, Y., Lyu, D., Ouyang, Y., Zhang, Q., & Yan, Y. (2021) · Biomaterials Advances · doi:10.1016/j.msec.2021.112627 · Cited by 14 · see citing works

Efficient Gene Delivery Based on Guanidyl‐Nucleic Acid Molecular Interactions

Wang, D., Song, J., Wang, J., Zhang, Z., Shen, Q. X., Wang, J., Guo, H., Wang, R., Xie, C., Lu, W., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004783 · Cited by 14 · see citing works

Progress in research and development of temozolomide brain-targeted preparations: a review

Yang, J., Xu, Y., Fu, Z., Chen, J., Fan, W., & Wu, X. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2119243 · Cited by 13 · see citing works

Arsenic trioxide and Erlotinib loaded in RGD‐modified nanoliposomes for targeted combination delivery to PC3 and PANC‐1 cell lines

Khosravani, F., Mir, H., Mirzaei, A., Kobarfard, F., Bardania, H., & Hosseini, E. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2401 · Cited by 13 · see citing works

Mechanism and clinical application of thymosin in the treatment of lung cancer

Liu, Y., & Lu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237978 · Cited by 13 · see citing works

Polyaspartamide based hydrogel with cell recruitment properties for the local administration of hydrophobic anticancer drugs

Fiorica, C., Ventura, C. A., Pitarresi, G. L., & Giammona, G. (2019) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2019.02.014 · Cited by 13 · see citing works

RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

Huang, C., Liu, F.-R., Feng, Q., Pan, X.-Y., Song, S., & Yang, J.-L. (2021) · BMC Cancer · doi:10.1186/s12885-021-08056-4 · Cited by 13 · see citing works

Polymeric blends of okra gum/gelatin prepared by aqueous polymerization technique: their characterization and toxicological evaluation

Maryam, S., Barkat, K., Khalid, S. H., Mehmood, Y., Syed, M. A., Malik, N. S., & Aslam, M. (2021) · Polymer Bulletin · doi:10.1007/s00289-021-03561-9 · Cited by 12 · see citing works

Intelligent Drug Delivery by Peptide-Based Dual-Function Micelles

Wan, D., Liu, Y., Guo, X., Zhang, J., & Pan, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179698 · Cited by 12 · see citing works

Dual-modal polypeptide-containing contrast agents for magnetic resonance/fluorescence imaging

Zheng, S.-Y., Tang, W., Zhang, M., Yan, J., Liu, F., Yan, G., Liang, S., & Wang, Y. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106161 · Cited by 11 · see citing works

An MMP-2 sensitive and reduction-responsive prodrug amphiphile for actively targeted therapy of cancer by hierarchical cleavage

Zhang, X., Dai, L., Ding, Y., Liu, Q., Li, X., Liu, M., Meng, M., Pan, J., Xi, R., & Yin, Y. (2022) · Chemical Communications · doi:10.1039/d2cc05586d · Cited by 10 · see citing works

The Effects of the Carrier and Ligand Spatial Conformation on RNA Nanodrug Cell Delivery

Zhang, Z., Li, S., Wang, H., & Shan, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02270 · Cited by 9 · see citing works

Targeted pH-Activated Peptide-Based Nanomaterials for Combined Photodynamic Therapy with Immunotherapy

Sun, B., Yang, H., Li, Y., Scheerstra, J. F., van Stevendaal, M. H. M. E., Li, S., & van Hest, J. C. M. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00141 · Cited by 9 · see citing works

Peptide and Antibody Functionalized Nanoparticles: Active Targeting Strategies for Next-Generation Contrast Agents and Drug Delivery Systems

Nikhar, S., Jahan, A., Mahato, T., & Giri, A. S. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c05449 · Cited by 8 · see citing works

Fe@Fe 3 Ge 2 nanoparticles for MR imaging-guided NIR-driven photodynamic therapy in vivo

Zhou, P., Pan, L., Deng, G., Zhou, Z., Zhao, H., Peng, C., & Yang, S. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01173k · Cited by 8 · see citing works

Current status and advances in arginine‐glycine‐aspartic acid peptide‐based molecular imaging to evaluate the effects of anti‐angiogenic therapies

Cui, J., & Yue, J. (2019) · Precision Radiation Oncology · doi:10.1002/pro6.60 · Cited by 8 · see citing works

Antisense oligonucleotide repress telomerase activity via manipulating alternative splicing or translation

Zhou, J., Li, T., Geng, X., Sui, L., & Wang, F. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.10.034 · Cited by 7 · see citing works

In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles

Yun, D., Liu, D., Liu, J., Feng, Y., Chen, H., Chen, S., & Xie, Q. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112644 · Cited by 7 · see citing works

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis

Zhao, J., Lin, B.-L., Luo, C. H., Yi, Y.-L., Huang, P., Chen, Y., Zhao, S., Huang, Z.-J., Ma, X., & Huang, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05794-4 · Cited by 7 · see citing works

Cyclic RGD modified dextran-quercetin polymer micelles for targeted therapy of breast cancer

Yang, C., Ma, H., Liang, Z., Zhuang, Y., Hu, L., Zhang, K., Huang, L., Li, M., Zhang, S., & Zhen, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142272 · Cited by 7 · see citing works

Long-Circulating Lipid Nanospheres Loaded with Flurbiprofen Axetil for Targeted Rheumatoid Arthritis Treatment

Chen, Z., Liu, Z., Wang, S., Cheng, C., Sun, X., Liu, Z., Wei, J., Jiang, J., Lan, H., Zhou, M., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s419502 · Cited by 7 · see citing works

Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

Huang, C., Liu, F.-R., Feng, Q., Pan, X.-Y., Song, S., & Yang, J.-L. (2021) · BMC Cancer · doi:10.1186/s12885-021-08120-z · Cited by 7 · see citing works

Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: Cancer, Diabetes, and Cardiovascular Disease

Banerjee, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-1761-7_25 · Cited by 6 · see citing works

Cationic RGD peptidomimetic nanoconjugates as effective tumor targeting gene delivery vectors with antimicrobial potential

Ahmadi, Z., Jha, D., Gautam, H. K., Kumar, P., & Sharma, A. K. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106197 · Cited by 6 · see citing works

Effect of neutrophil-like melanin biomimic photothermal nanoparticles on glomerular mesangial cells in rats with gestational diabetic nephropathy

Li, J., Zhang, J., Lu, Y., & Zhang, C. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100458 · Cited by 5 · see citing works

Nanoarchitectures to Deliver Nucleic Acid Drugs to Disease Sites

Komiyama, M., & Sumaoka, J. (2023) · ChemNanoMat · doi:10.1002/cnma.202300069 · Cited by 5 · see citing works

Synthesis of 18F‐radiolabeled organophosphine fluorides for thiol‐chemoselective peptide conjugation

Zhuang, H., Guo, Z., Zhuang, R., & Zhang, X. (2020) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3882 · Cited by 5 · see citing works

The effect of a novel drug delivery system using encapsulated antimicrobial peptide Protonectin (IL-12) into Nano micelle PEG-PCL on A549 adenocarcinoma lung cell line

Eskandari, R., Asoodeh, A., Mousavi, S.-D., & Firouzi, Z. (2021) · Journal of Polymer Research · doi:10.1007/s10965-021-02699-4 · Cited by 4 · see citing works

Thiosugar-functionalized gold(I)-NHC complexes as selective anticancer agents for potential targeted therapy

Giorgi, E., Biver, T., Mannelli, M., Gamberi, T., Becatti, M., Sabatino, G., Peroni, E., Monasson, O., Cirri, D., Gabbiani, C., et al. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1724206 · Cited by 3 · see citing works

Collagen-Peptide-Based Drug Delivery Strategies

Jayaraman, A., Price, C., Sullivan, M. O., & Kiick, K. L. (2020) · Technology & Innovation · doi:10.21300/21.4.2020.9 · Cited by 3 · see citing works

Nanoparticles for Cancer Therapy

Jayaraman, M., Dutta, P., Telang, J., & B., S. K. B. (2021) · Springer eBooks · doi:10.1007/978-981-15-7564-8_1 · Cited by 3 · see citing works

Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells

Niu, L., Zhou, H., Lian, Y., Gao, Y., Liu, Y., Gu, R., Wu, Z., Zhu, X., Gan, H. K., Meng, Z., et al. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.03.002 · Cited by 3 · see citing works

RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis

Danhier, F., Breton, A. L., & Véronique Préat, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 959 · see citing works

αvβ3 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment

Kesharwani, P., Chandra, J., Karim, S., Gupta, G., Karwasra, R., & Sharma, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105663 · Cited by 38 · see citing works

cRGD functionalised nanocarriers for targeted delivery of bioactives

Gajbhiye, K. R., Gajbhiye, V., Siddiqui, I. A., & Gajbhiye, J. M. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1473409 · Cited by 81 · see citing works

A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy

Park, J. Y., Singha, K., Son, S., Kim, J., Namgung, R., Yun, C.-O., & Kim, W.-J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.64 · Cited by 99 · see citing works

Application of RGD Ligands Targeting Integrin α_vβ_3 in Anti-tumor Angiogenesis

Yuan, Z. (2013) · Zhongguo shengwu huaxue yu fenzi shengwu xuebao